メインコンテンツにスキップ

SCOPE Europe

SCOPE Europe

「医薬品AI応用における誇大広告から現実へ」(英語講演)

Ian Kerman

|

Client Solutions Architect

Life science companies continue to struggle to leverage new AI technologies to enhance the safety and efficacy of therapeutics. The key is identifying clear use cases where AI can maximize impact by supporting bench scientists, data scientists, and medical writers. This presentation will cover three such use cases:​

1. Utilizing GPTs for structured content authoring​
2. Automating data transformation for eCTD standardization​
3. QSP model creation to improve target ID, PK/PD, and clinical trial design​

Powered by Translations.com GlobalLink Web Software